Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

SOX2 is a stem cell-associated pluripotency transcription factor whose role in neuronal populations is undefined. Here we present the RNA-sequencing based transcriptome profiles of control ( ) and SOX2 conditional knock-out ( ) mice at four time points in one 24-h circadian cycle. The raw sequencing data were deposited to ArrayExpress database at EMBL-EBI (https://www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-7496. Results of rhythmicity analysis, differential expression analysis, network prediction, and potential target identification stemming from the RNA-sequencing dataset are also given in this article. The interpretation and discussion of these data can be found in the related research article entitled "SOX2-dependent transcription in clock neurons promotes the robustness of the central circadian pacemaker." Cheng et al. 2019.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488738PMC
http://dx.doi.org/10.1016/j.dib.2019.103909DOI Listing

Publication Analysis

Top Keywords

central circadian
8
rna-sequencing data
4
data highlighting
4
highlighting time-of-day-dependent
4
time-of-day-dependent transcriptome
4
transcriptome central
4
circadian pacemaker
4
pacemaker -deficient
4
-deficient mice
4
mice sox2
4

Similar Publications

Cancer patients experience circadian rhythm disruptions during and after chemotherapy that can contribute to debilitating side effects. It is unknown how chemotherapy mediates circadian disruptions, and specifically the extent to which these disruptions occur at the level of the principal clock, the suprachiasmatic nuclei (SCN) of the hypothalamus. In the present study, we assessed how the commonly used chemotherapeutic, paclitaxel, impacts the SCN molecular clock and SCN-dependent behavioral adaptations to circadian challenges in female mice.

View Article and Find Full Text PDF

Study Objectives: Dim light melatonin onset (DLMO) is the best-established marker of central circadian phase and may contribute to unraveling the role of the circadian system in obesity. This study evaluated DLMO among individuals with obesity using a home-based assessment and explored its clinical correlates and procedural variations.

Method: Fifty-eight women (mean [SD] age 40.

View Article and Find Full Text PDF

External Cues as Transducers of Peripheral Tissue-Specific Molecular Clocks to Regulate Systemic Circadian Rhythms and Metabolism.

FASEB J

September 2025

Key Laboratory of Adolescent Health Assessment and Exercise Intervention, Ministry of Education, East China Normal University, Shanghai, China.

The molecular clock exhibits distinct characteristics across various tissues and can be synchronized by particular stimuli. Furthermore, there is an intricate interplay among the molecular clocks within different tissues. In this context, we present an overview of the tissue-specific molecular clock and discuss pivotal nonphotic regulators that govern the host's circadian rhythms and metabolic processes.

View Article and Find Full Text PDF

Objectives: Bladder cancer is a common malignancy with high incidence and poor prognosis. N-methyladenosine (mA) modification is widely involved in diverse physiological processes, among which the mA recognition protein YTH N-methyladenosine RNA binding protein F2 (YTHDF2) plays a crucial role in bladder cancer progression. This study aims to elucidate the molecular mechanism by which O-linked -acetylglucosamine (O-GlcNAc) modification of YTHDF2 regulates its downstream target, period circadian regulator 1 (), thereby promoting bladder cancer cell proliferation.

View Article and Find Full Text PDF

Sleep Dysfunction in Older Age Parkinson's Disease.

Sleep Med Clin

September 2025

Older Person Medical Clinic, Suite 3/18 Lambton Road, Broadmeadow, New South Wales, 2292, Australia.

Sleep and circadian disturbances are prevalent in Parkinson's disease (PD) and become increasingly complex in older adults, where aging-related changes, comorbidities, and polypharmacy further disrupt sleep. This review explores the pathophysiology of sleep and circadian dysfunction in aging and PD, highlighting the impact of neurodegenerative changes and neurotransmitter dysregulation. Key sleep disorders in older adults with PD are discussed with a focus on their epidemiology, assessment, and tailored management.

View Article and Find Full Text PDF